Submission marks the first time data from the AVA™ Emulation System will be evaluated as part of the FDA qualification process, reinforcing confidence in scalable human-relevant liver models BOSTON — Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, today announced it has submitted its FDA Innovative Science and Technology Approaches for New Drugs (ISTAND) […]
Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development PRINCETON, N.J. — Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™ cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on […]
Countable Labs’ full portfolio is now available through distribution agreement with PRIMETECH PALO ALTO, Calif. — Countable Labs, developer of Countable PCR, a next-generation PCR technology that enables direct, single-molecule quantification, today announced a distribution partnership with PRIMETECH Corporation to bring its full portfolio of Countable PCR-based solutions to customers in Japan. The agreement follows […]
Next-generation upgrade strengthens data comparability and compliance—without changing trusted instrumentation San Jose – Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, today announced the launch of Vi-CELL BLU 2.0 Viability Analyzer Software, a major upgrade that enables laboratories to modernize cell viability workflows while maintaining data continuity, […]
Acquisition adds regulated bioanalytical and CMC services, diagnostic reagents, and workflow critical products to support translational, clinical, and commercial development SHAKER HEIGHTS, Ohio — VION Biosciences (“VION”), a life sciences company building integrated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Prolytix, a provider of regulated bioanalytical […]
Acquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery Combines HCD’s human pancreatic beta cell models with Revvity’s capabilities in cell analysis, detection, high-content screening and gene editing Expands Revvity’s ability to support customers across the research-to-clinic continuum, including emerging applications in clinical development and […]
WALTHAM, Mass. — NanoMosaic, a pioneer in multiomic analytical technologies for cell and gene therapy development and manufacturing, today announced its participation in a multidisciplinary team awarded up to $39.2 million by the Advanced Research Projects Agency for Health (ARPA-H). Led by investigators at the Mass General Brigham Gene and Cell Therapy Institute and Massachusetts […]
VIENNA — Cell-free DNA assembly pioneer, Ribbon Bio, has today announced the appointment of Jay Therrien as Chief Business Officer. Therrien joins Ribbon’s executive leadership team where he will lead the company’s commercial strategy and growth initiatives. Therrien brings over two decades of experience building and leading commercial organizations across the life sciences and genomics […]
LOS ANGELES — Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today announced the availability of HCR™ Gold IF on Biocare Medical’s ONCORE Pro X, a fully open automated slide staining system for research laboratories. Powered by the HCR™ HiFi Encoder, HCR™ Gold IF lets researchers build multiplex immunofluorescence assays with any off-the-shelf […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company’s board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of service as a director. Koh joined Agilent’s board in 2003 and served as independent chair from 2017 until […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
